questionsmedicales.fr
Maladies cardiovasculaires
Maladies vasculaires
Vascularite
Vascularite : Questions médicales fréquentes
Termes MeSH sélectionnés :
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Vascularite : Questions médicales les plus fréquentes",
"headline": "Vascularite : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Vascularite : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-06-06",
"dateModified": "2025-03-03",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Vascularite"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Maladies vasculaires",
"url": "https://questionsmedicales.fr/mesh/D014652",
"about": {
"@type": "MedicalCondition",
"name": "Maladies vasculaires",
"code": {
"@type": "MedicalCode",
"code": "D014652",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C14.907"
}
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Aortite",
"alternateName": "Aortitis",
"url": "https://questionsmedicales.fr/mesh/D001025",
"about": {
"@type": "MedicalCondition",
"name": "Aortite",
"code": {
"@type": "MedicalCode",
"code": "D001025",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C14.907.940.080"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Artérite",
"alternateName": "Arteritis",
"url": "https://questionsmedicales.fr/mesh/D001167",
"about": {
"@type": "MedicalCondition",
"name": "Artérite",
"code": {
"@type": "MedicalCode",
"code": "D001167",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C14.907.940.090"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Endartérite",
"alternateName": "Endarteritis",
"url": "https://questionsmedicales.fr/mesh/D004692",
"about": {
"@type": "MedicalCondition",
"name": "Endartérite",
"code": {
"@type": "MedicalCode",
"code": "D004692",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C14.907.940.090.340"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Syndrome de Cogan",
"alternateName": "Cogan Syndrome",
"url": "https://questionsmedicales.fr/mesh/D055952",
"about": {
"@type": "MedicalCondition",
"name": "Syndrome de Cogan",
"code": {
"@type": "MedicalCode",
"code": "D055952",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C14.907.940.320"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Phlébite",
"alternateName": "Phlebitis",
"url": "https://questionsmedicales.fr/mesh/D010689",
"about": {
"@type": "MedicalCondition",
"name": "Phlébite",
"code": {
"@type": "MedicalCode",
"code": "D010689",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C14.907.940.740"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Thrombophlébite",
"alternateName": "Thrombophlebitis",
"url": "https://questionsmedicales.fr/mesh/D013924",
"about": {
"@type": "MedicalCondition",
"name": "Thrombophlébite",
"code": {
"@type": "MedicalCode",
"code": "D013924",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C14.907.940.740.910"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Syndrome de Lemierre",
"alternateName": "Lemierre Syndrome",
"url": "https://questionsmedicales.fr/mesh/D057831",
"about": {
"@type": "MedicalCondition",
"name": "Syndrome de Lemierre",
"code": {
"@type": "MedicalCode",
"code": "D057831",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C14.907.940.740.910.500"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Syndrome de Lemierre",
"alternateName": "Lemierre Syndrome",
"url": "https://questionsmedicales.fr/mesh/D057831",
"about": {
"@type": "MedicalCondition",
"name": "Syndrome de Lemierre",
"code": {
"@type": "MedicalCode",
"code": "D057831",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C14.907.940.740.910.500"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Vascularite rétinienne",
"alternateName": "Retinal Vasculitis",
"url": "https://questionsmedicales.fr/mesh/D031300",
"about": {
"@type": "MedicalCondition",
"name": "Vascularite rétinienne",
"code": {
"@type": "MedicalCode",
"code": "D031300",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C14.907.940.815"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Vascularite systémique",
"alternateName": "Systemic Vasculitis",
"url": "https://questionsmedicales.fr/mesh/D056647",
"about": {
"@type": "MedicalCondition",
"name": "Vascularite systémique",
"code": {
"@type": "MedicalCode",
"code": "D056647",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C14.907.940.897"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Thromboangéite oblitérante",
"alternateName": "Thromboangiitis Obliterans",
"url": "https://questionsmedicales.fr/mesh/D013919",
"about": {
"@type": "MedicalCondition",
"name": "Thromboangéite oblitérante",
"code": {
"@type": "MedicalCode",
"code": "D013919",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C14.907.940.905"
}
}
}
],
"about": {
"@type": "MedicalCondition",
"name": "Vascularite",
"alternateName": "Vasculitis",
"code": {
"@type": "MedicalCode",
"code": "D014657",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "David S Younger",
"url": "https://questionsmedicales.fr/author/David%20S%20Younger",
"affiliation": {
"@type": "Organization",
"name": "Department of Medicine, Section of Neuroscience, City University of New York School of Medicine, New York, NY, USA; Department of Neurology, White Plains Hospital, White Plains, NY, USA. Electronic address: youngd01@nyu.edu."
}
},
{
"@type": "Person",
"name": "Tanaz A Kermani",
"url": "https://questionsmedicales.fr/author/Tanaz%20A%20Kermani",
"affiliation": {
"@type": "Organization",
"name": "Division of Rheumatology, University of California, Los Angeles, Los Angeles, CA, USA."
}
},
{
"@type": "Person",
"name": "Christian Pagnoux",
"url": "https://questionsmedicales.fr/author/Christian%20Pagnoux",
"affiliation": {
"@type": "Organization",
"name": "Department of Medicine, Division of Rheumatology, Mount Sinai Hospital, Toronto."
}
},
{
"@type": "Person",
"name": "Cristina Ponte",
"url": "https://questionsmedicales.fr/author/Cristina%20Ponte",
"affiliation": {
"@type": "Organization",
"name": "Rheumatology Department, Hospital de Santa Maria - Centro Hospitalar Universitário Lisboa Norte, Centro Académico de Medicina de Lisboa, Lisbon, Portugal. cristinadbponte@gmail.com."
}
},
{
"@type": "Person",
"name": "Nikita Khmelinskii",
"url": "https://questionsmedicales.fr/author/Nikita%20Khmelinskii",
"affiliation": {
"@type": "Organization",
"name": "Rheumatology Department, Hospital de Santa Maria - Centro Hospitalar Universitário Lisboa Norte, Centro Académico de Medicina de Lisboa, Lisbon, Portugal."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Exploring the Impact of Language Concordance on Cancer Communication.",
"datePublished": "2022-09-16",
"url": "https://questionsmedicales.fr/article/36112970",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1200/OP.22.00040"
}
},
{
"@type": "ScholarlyArticle",
"name": "EMPATIA: A Guide for Communicating the Diagnosis of Neuromuscular Diseases.",
"datePublished": "2022-08-09",
"url": "https://questionsmedicales.fr/article/36011430",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3390/ijerph19169792"
}
},
{
"@type": "ScholarlyArticle",
"name": "Bushfire Smoke and Children's Health-Exploring a Communication Gap.",
"datePublished": "2022-09-29",
"url": "https://questionsmedicales.fr/article/36231731",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3390/ijerph191912436"
}
},
{
"@type": "ScholarlyArticle",
"name": "Documenting language barriers in a general hospital psychiatry setting.",
"datePublished": "2023-04-25",
"url": "https://questionsmedicales.fr/article/37097920",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1177/13634615231163993"
}
},
{
"@type": "ScholarlyArticle",
"name": "The role of language barriers on efficacy of rapid response teams.",
"datePublished": "2022-11-24",
"url": "https://questionsmedicales.fr/article/36400063",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1080/21548331.2022.2150416"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Maladies cardiovasculaires",
"item": "https://questionsmedicales.fr/mesh/D002318"
},
{
"@type": "ListItem",
"position": 3,
"name": "Maladies vasculaires",
"item": "https://questionsmedicales.fr/mesh/D014652"
},
{
"@type": "ListItem",
"position": 4,
"name": "Vascularite",
"item": "https://questionsmedicales.fr/mesh/D014657"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Vascularite - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Vascularite",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-03",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Vascularite",
"description": "Comment diagnostiquer une vascularite ?\nQuels tests sanguins sont utilisés ?\nQuels symptômes indiquent une vascularite ?\nLa biopsie est-elle toujours nécessaire ?\nQuels spécialistes consultent pour une vascularite ?",
"url": "https://questionsmedicales.fr/mesh/D014657?mesh_terms=Communication+Barriers&page=2#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Vascularite",
"description": "Quels sont les symptômes courants de la vascularite ?\nLa vascularite peut-elle causer des douleurs articulaires ?\nY a-t-il des symptômes neurologiques associés ?\nLes éruptions cutanées sont-elles spécifiques ?\nLa vascularite peut-elle affecter les organes internes ?",
"url": "https://questionsmedicales.fr/mesh/D014657?mesh_terms=Communication+Barriers&page=2#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Vascularite",
"description": "Peut-on prévenir la vascularite ?\nLes vaccinations sont-elles recommandées ?\nComment éviter les déclencheurs ?\nLe suivi médical est-il important ?\nY a-t-il des conseils diététiques ?",
"url": "https://questionsmedicales.fr/mesh/D014657?mesh_terms=Communication+Barriers&page=2#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Vascularite",
"description": "Quels traitements sont disponibles pour la vascularite ?\nLes corticostéroïdes sont-ils efficaces ?\nQuand utilise-t-on des immunosuppresseurs ?\nY a-t-il des traitements alternatifs ?\nLe traitement est-il à long terme ?",
"url": "https://questionsmedicales.fr/mesh/D014657?mesh_terms=Communication+Barriers&page=2#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Vascularite",
"description": "Quelles sont les complications possibles de la vascularite ?\nLa vascularite peut-elle entraîner des problèmes rénaux ?\nQuels risques cardiovasculaires sont associés ?\nLes complications sont-elles réversibles ?\nComment surveiller les complications ?",
"url": "https://questionsmedicales.fr/mesh/D014657?mesh_terms=Communication+Barriers&page=2#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Vascularite",
"description": "Quels sont les facteurs de risque de la vascularite ?\nL'âge influence-t-il le risque de vascularite ?\nLes infections peuvent-elles déclencher une vascularite ?\nLe tabagisme est-il un facteur de risque ?\nCertaines maladies auto-immunes augmentent-elles le risque ?",
"url": "https://questionsmedicales.fr/mesh/D014657?mesh_terms=Communication+Barriers&page=2#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer une vascularite ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le diagnostic repose sur des analyses sanguines, des biopsies et des examens d'imagerie."
}
},
{
"@type": "Question",
"name": "Quels tests sanguins sont utilisés ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests comme la vitesse de sédimentation et les marqueurs inflammatoires sont courants."
}
},
{
"@type": "Question",
"name": "Quels symptômes indiquent une vascularite ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Symptômes incluent fatigue, fièvre, douleurs articulaires et éruptions cutanées."
}
},
{
"@type": "Question",
"name": "La biopsie est-elle toujours nécessaire ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Non, elle est souvent utilisée si les tests sanguins ne sont pas concluants."
}
},
{
"@type": "Question",
"name": "Quels spécialistes consultent pour une vascularite ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les rhumatologues et les médecins internistes sont souvent impliqués dans le diagnostic."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes courants de la vascularite ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent fatigue, fièvre, douleurs musculaires et éruptions cutanées."
}
},
{
"@type": "Question",
"name": "La vascularite peut-elle causer des douleurs articulaires ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les douleurs articulaires sont fréquentes et peuvent être sévères."
}
},
{
"@type": "Question",
"name": "Y a-t-il des symptômes neurologiques associés ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des maux de tête, des troubles de la vision et des engourdissements peuvent survenir."
}
},
{
"@type": "Question",
"name": "Les éruptions cutanées sont-elles spécifiques ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elles peuvent varier, mais souvent apparaissent sous forme de plaques ou de purpura."
}
},
{
"@type": "Question",
"name": "La vascularite peut-elle affecter les organes internes ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elle peut toucher les reins, les poumons et le cœur, entraînant des complications."
}
},
{
"@type": "Question",
"name": "Peut-on prévenir la vascularite ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Il n'existe pas de méthode de prévention spécifique, mais un suivi médical régulier aide."
}
},
{
"@type": "Question",
"name": "Les vaccinations sont-elles recommandées ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les vaccinations peuvent aider à prévenir certaines infections qui aggravent la vascularite."
}
},
{
"@type": "Question",
"name": "Comment éviter les déclencheurs ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Éviter le tabac, le stress et les infections peut réduire les risques de poussées."
}
},
{
"@type": "Question",
"name": "Le suivi médical est-il important ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, un suivi régulier permet d'ajuster le traitement et de surveiller les symptômes."
}
},
{
"@type": "Question",
"name": "Y a-t-il des conseils diététiques ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une alimentation équilibrée et riche en antioxydants peut soutenir la santé vasculaire."
}
},
{
"@type": "Question",
"name": "Quels traitements sont disponibles pour la vascularite ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les corticostéroïdes et les immunosuppresseurs sont couramment utilisés."
}
},
{
"@type": "Question",
"name": "Les corticostéroïdes sont-ils efficaces ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, ils réduisent l'inflammation et soulagent les symptômes rapidement."
}
},
{
"@type": "Question",
"name": "Quand utilise-t-on des immunosuppresseurs ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Ils sont utilisés pour les cas graves ou réfractaires aux corticostéroïdes."
}
},
{
"@type": "Question",
"name": "Y a-t-il des traitements alternatifs ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des thérapies biologiques peuvent être envisagées dans certains cas spécifiques."
}
},
{
"@type": "Question",
"name": "Le traitement est-il à long terme ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Cela dépend de la gravité et de la réponse au traitement, souvent plusieurs mois."
}
},
{
"@type": "Question",
"name": "Quelles sont les complications possibles de la vascularite ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications incluent des lésions organiques, des AVC et des problèmes cardiaques."
}
},
{
"@type": "Question",
"name": "La vascularite peut-elle entraîner des problèmes rénaux ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elle peut causer une insuffisance rénale aiguë ou chronique."
}
},
{
"@type": "Question",
"name": "Quels risques cardiovasculaires sont associés ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les patients peuvent avoir un risque accru de maladies cardiaques et d'AVC."
}
},
{
"@type": "Question",
"name": "Les complications sont-elles réversibles ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines complications peuvent être réversibles avec un traitement précoce."
}
},
{
"@type": "Question",
"name": "Comment surveiller les complications ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des examens réguliers et des tests de fonction organique sont essentiels."
}
},
{
"@type": "Question",
"name": "Quels sont les facteurs de risque de la vascularite ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les facteurs incluent des antécédents familiaux, des infections et certains médicaments."
}
},
{
"@type": "Question",
"name": "L'âge influence-t-il le risque de vascularite ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certaines formes de vascularite sont plus fréquentes chez les personnes âgées."
}
},
{
"@type": "Question",
"name": "Les infections peuvent-elles déclencher une vascularite ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des infections virales ou bactériennes peuvent être des déclencheurs."
}
},
{
"@type": "Question",
"name": "Le tabagisme est-il un facteur de risque ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le tabagisme est associé à un risque accru de vascularite."
}
},
{
"@type": "Question",
"name": "Certaines maladies auto-immunes augmentent-elles le risque ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des maladies comme le lupus ou la polyarthrite rhumatoïde sont des facteurs de risque."
}
}
]
}
]
}
Patients with cancer who have limited English proficiency are more likely to experience inequities in cancer knowledge, timely care, and access to clinical trials. Matching patients with language-conc...
We used the RIAS, a validated tool for qualitative coding and quantitative analysis, to evaluate interactions between 34 patients and 16 clinicians. The pairings were stratified into dyads: English la...
Spanish language-concordant clinicians had almost two-fold greater number of statements about biomedical information than English language-concordant clinicians. Spanish language-concordant patients h...
Language concordance may facilitate more effective biomedical counseling and therapeutic relationships between oncology clinicians and patients. Future research should further explore the impact of la...
Neuromuscular diseases comprise a heterogeneous group of genetic syndromes that lead to progressive muscle weakness, resulting in functional limitation. There is a gap in the literature regarding the ...
Developing a guide to reduce communication barriers in the diagnosis of neuromuscular diseases....
Systematic review, after searching the descriptors ("Muscular Diseases" OR "Neuromuscular Diseases") AND ("Truth Disclosure" OR "Bad news communication" OR "Breaking bad News") in the Pubmed, Bireme, ...
16 articles were submitted to the final analysis, giving rise to seven steps to support the communication process. These are Empathy, Message, Prognosis, Reception, Time, Individualization, and Autono...
The empathic transmission of the message and the prognosis must accommodate the feelings of the interlocutors with different information needs. In this way, communication planning optimizes the time a...
The "Black Summer" bushfires of 2019/2020 in Australia generated smoke that persisted for over three months, mainly affecting Eastern Australia. Most communication strategies focused on the fire itsel...
Previous research has demonstrated that without the use of professional interpreters, language barriers interfere with patient care. The literature recommends documenting the presence of language barr...
Rapid response (RR) systems are associated with decreased hospital mortality. Systemic biases and inequities can negatively impact RR outcomes. Language barriers between patients and providers are ass...
We analyzed all adult hospitalized patients who experienced a RR over one year (January 2020 to December 2020) at a tertiary care academic medical center. We used an objective scoring system to establ...
Of 1133 patients, 42 identified as PLS and 1091 as PLE. In multivariable analyses, PLS patients had significantly higher disease severity scores, as measured by deterioration index score (8.2, p = 0.0...
Our study found that PLS patients had increased disease severity at the time of RRs and increased LOS after RRs. However, the disparity in LOS was not mitigated when controlling for disease severity a...
This article discusses the barriers that prevent deaf people from participating in clinical trials and offers recommendations to overcome these barriers and ensure equal access to study participation....
Between April and May 2022, we conducted six focus groups with 20 deaf adults who use American Sign Language, all of whom had previous experience as research study participants. Focus group prompts qu...
Focus group participants unanimously agreed that, compared to the general hearing population, deaf sign language users lack equivalent access to clinical trial participation. Reported barriers include...
The lack of communication accessibility is the most common factor preventing deaf sign language users from participating in clinical trials. This article provides recommendations for hearing researche...
To describe communication strategies for clinical practice that allow practitioners to work more effectively with marginalised population groups and to discuss how to incorporate these into medical pr...
Active practitioners working in inclusion health and people with lived experience of homelessness and the asylum-seeking process shared their perspectives in the symposium at the 2022 International Co...
We describe the perspectives shared at the symposia under two main themes: communication needs in people experiencing homelessness and migrant populations, and trauma-informed practice....
People experiencing homelessness have more communication challenges compared to the general adult population. Migrant, refugee, and asylum-seeking populations also face the complexity of negotiating u...
This study focused on Ukrainian refugees and migrants, a population that, with an ongoing war, is expected to grow in Germany. Over 1 million Ukrainians with exceptional legal status and access to pub...
A qualitative study was conducted from February 2023 to April 2023. Thirty semi-structured interviews were performed with Ukrainian migrants and refugees. The interviews were transcribed verbatim, org...
Ukrainian migrants and refugees experience similar barriers while accessing German healthcare services. Predominantly, language barriers and a lack of understanding of the German healthcare system pos...
This research study emphasizes the importance of addressing cultural and structural barriers to improve healthcare accessibility and utilization for Ukrainian refugees and migrants in Germany to bette...
Accessing professional medical interpreters for brief, low risk exchanges can be challenging. Machine translation (MT) for verbal communication has the potential to be a useful clinical tool, but few ...
We evaluated the quality of three MT applications for English-Spanish and English-Mandarin two-way interpretation of low complexity brief clinical communication compared with human interpretation....
Audio-taped phrases were interpreted via human and 3 MT applications. Bilingual assessors evaluated the quality of MT interpretation on four assessment categories (accuracy, fluency, meaning, and clin...
Proportion of interpretation exchanges deemed acceptable, defined as a composite score of 16 or greater out of 20 based on the four assessment categories....
For English to Spanish, the proportion of MT-interpreted phrases scored as acceptable ranged from 0.68 to 0.84, while for English to Mandarin, the range was from 0.62 to 0.76. Both Spanish/Mandarin to...
While MT interpretation was better for English to Spanish or Mandarin than the reverse, the overall quality of MT interpretation was poor for two-way clinical communication. Clinicians should advocate...
Few studies have focused on value structures, experiences, and cultural diversity as it relates to bioswale planning and implementation. We used 'Point of Opportunity Interactions' to understand previ...